Cargando…
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
BACKGROUND: Ebola virus disease (EVD) is a highly lethal condition for which no specific treatment has proven efficacy. In September 2014, while the Ebola outbreak was at its peak, the World Health Organization released a short list of drugs suitable for EVD research. Favipiravir, an antiviral devel...
Ejemplares similares
-
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
por: Sissoko, Daouda, et al.
Publicado: (2016) -
Psychosocial impacts of COVID-19 in the Guinean population. An online cross-sectional survey
por: Touré, Almamy Amara, et al.
Publicado: (2021) -
Detection of Marburg Virus Disease in Guinea
por: Koundouno, Fara R., et al.
Publicado: (2022) -
Biological and Phytochemical Investigations on Caesalpinia benthamiana, a Plant Traditionally Used as Antimalarial in Guinea
por: Loua, Jean, et al.
Publicado: (2017) -
Prevalence of malaria and factors associated with infection in children aged 6 months to 9 years in Guinea: Results from a national cross-sectional study
por: Beavogui, Abdoul Habib, et al.
Publicado: (2020)